Welcome to LookChem.com Sign In|Join Free
  • or
Codoxime is a synthetic chemical compound belonging to the class of quinoxaline-1,4-dioxides, which is primarily used as a coccidiostat in veterinary medicine. It is effective in preventing and treating coccidiosis, a disease caused by protozoan parasites in the genus Eimeria, commonly affecting poultry. Codoxime works by inhibiting the growth and reproduction of these parasites, thereby reducing the severity of the infection and improving the overall health of the affected animals. The compound is typically administered in feed or water and is considered safe and effective when used according to the recommended dosages.

7125-76-0

7125-76-0 Suppliers

This product is a nationally controlled contraband or patented product, and the Lookchem platform doesn't provide relevant sales information.

7125-76-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 7125-76-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,1,2 and 5 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 7125-76:
(6*7)+(5*1)+(4*2)+(3*5)+(2*7)+(1*6)=90
90 % 10 = 0
So 7125-76-0 is a valid CAS Registry Number.
InChI:InChI=1/C20H24N2O5/c1-22-8-7-20-12-4-5-13(21-26-10-16(23)24)19(20)27-18-15(25-2)6-3-11(17(18)20)9-14(12)22/h3,6,12,14,19H,4-5,7-10H2,1-2H3,(H,23,24)/b21-13-/t12-,14+,19-,20-/m0/s1

7125-76-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name codoxime

1.2 Other means of identification

Product number -
Other names 6-Carboxymethylen-4,4-dimethyl-2-piperidon

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7125-76-0 SDS

7125-76-0Downstream Products

7125-76-0Relevant academic research and scientific papers

Reduced antinociception of opioids in rats and mice by vaccination with immunogens containing oxycodone and hydrocodone haptens

Pravetoni, Marco,Le Naour, Morgan,Tucker, Ashli M.,Harmon, Theresa M.,Hawley, Tara M.,Portoghese, Philip S.,Pentel, Paul R.

, p. 915 - 923 (2013)

Prescription opioids abuse and associated deaths are an emerging concern in the USA. Vaccination against prescription opioids may provide an alternative to pharmacotherapy. An oxycodone hapten containing a tetraglycine linker at the C6 position (6OXY(Gly)4OH) conjugated to keyhole limpet hemocyanin (KLH) has shown early proof-of-efficacy in rodents as a candidate immunogen (6OXY(Gly)4-KLH) for the treatment of oxycodone abuse. In this study, oxycodone-based and hydrocodone-based haptens were conjugated to KLH to generate immunogens that would recognize both oxycodone and hydrocodone. Vaccination with 6OXY(Gly)4-KLH increased drug binding in serum, reduced drug distribution to brain, and blunted analgesia for both oxycodone and hydrocodone. An analogous C6-linked hydrocodone vaccine blocked hydrocodone effects but less so than 6OXY(Gly)4-KLH. C8-Linked hydrocodone immunogens had only limited efficacy. Amide conjugation showed higher haptenation ratios and greater efficacy than thioether conjugation to maleimide activated KLH (mKLH). The 6OXY(Gly)4-KLH vaccine may be used for treatment of prescription opioid abuse.

VIRUS-LIKE PARTICLE VACCINES FOR OPIOID DRUGS

-

Page/Page column 28-29, (2021/09/11)

The present invention is directed to virus-like particles (VLPs) preferably derived from Qbeta bacteriophage which are engineered to conjugate to derivatives of opioid drugs. The opioid drugs are conjugated at high density to the virus-like particles to achieve long- lasting and high titer antibodies to the drugs of interest. Methods of treatment are also described.

COMPOSITIONS AND METHODS OF TREATING OPIOID ADDICTION

-

Paragraph 0275, (2014/04/17)

The present invention relates to conjugates and vaccine compositions for treatment of opioid addiction, and methods of use of these conjugates and compositions.